IDEX Corporation provided earnings guidance for the year 2022. For the period, the company's organic sales growth is projected to be approximately 12% over the prior year period, with a 9 % organic sales increase in the fourth quarter of 2022 versus the prior year period. The Company expects full year 2022 reported EPS attributable to IDEX of $7.75 to $7.80 (adjusted EPS attributable to IDEX of $8.04 to $8.09).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
222.3 USD | +0.04% | -1.69% | +2.40% |
May. 16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
May. 08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.40% | 16.83B | |
+20.40% | 6.53B | |
-4.89% | 5.18B | |
+3.41% | 4.61B | |
+8.01% | 3.16B | |
+39.10% | 2.01B | |
+108.07% | 1.76B | |
+3.01% | 1.25B | |
+22.41% | 1.05B | |
-8.25% | 854M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- Idex Corporation Provides Earnings Guidance for the Year 2022